Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07898254
NA

Testing Settings of NovaResp's cMAP® Software During Home PAP Therapy

Sponsor: NovaResp Technologies Inc

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to identify which settings of proactive therapy work best in OSA patients who regularly adhere to PAP therapy at home. The main question(s) it aims to answer are: * To assess how different settings of proactive therapy affect therapy effectiveness * To assess whether proactive therapy works similarly across different PAP devices Participants will undergo conventional APAP therapy and two modes of proactive therapy on two different PAP devices. Nights in which conventional APAP was used and nights in which proactive therapy was used to see which settings treated patients most effectively.

Official title: Experimental Evaluation of cMAP® Therapy Parameters Delivered Through Commercial Positive Airway Pressure (PAP) Devices in Adults Using PAP Therapy at Home

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2027-11-30

Completion Date

2028-11-30

Last Updated

2026-10-27

Healthy Volunteers

No

Interventions

DEVICE

Dynamic cMAP

Uses AI to make predictions of future apneic events. A deterministic algorithm uses output predictions to determine pressure.

DEVICE

Direct cMAP

Uses AI to directly determine the therapy pressure to prevent future apneic events

Locations (1)

NovaResp Technologies Inc.

Halifax, Nova Scotia, Canada